AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Identify Which Aristocrats Etf Has Most Growth Upside by examining momentum, holdings, and valuation factors informing future growth.
28,380 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
A new tech-specific volatility metric is approaching its highest level in two decades, underscoring rising nerves aro...
A near-40 couple with $86,000 in debt is told they can still reach millions in retirement after paying off debt and p...
Nike delivered a quarterly beat that sent its shares higher, but investors kept a close eye on tariffs and future gui...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
Amazon is raising 25 billion in long term bonds to finance its AI and cloud expansion, as executives outline a roughl...
Lumentum shares jumped about 12% on a $2 billion NVIDIA partnership, as AI data-center buildout and robust backlog un...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Shareholders allege Nvidia hid how much crypto miners boosted gaming GPU sales. The case could reshape disclosures ac...
This week, mortgage rates tick slightly higher but remain near the 6.5% level, according to Freddie Mac. The latest d...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...